Pharma channel feed

Te­va agrees to pay $225M in fines to set­tle DOJ charges of price-fix­ing gener­ic drugs

Last year

Pfiz­er's ma­ter­nal RSV vac­cine ap­proved to help pro­tect new­borns

Last year
FDA+

US Patent and Trade­mark Of­fice to hear patent chal­lenge over ex­per­i­men­tal seizure treat­ment

Last year
Law

Alk­er­mes' $194M pay­ment from Janssen gets ap­proval from court

Last year
Law

FDA sets Oc­to­ber ad­comm to dis­cuss full ap­proval for Am­gen’s Lumakras to treat sec­ond-line lung can­cer

Last year
FDA+

Af­ter two flops, Roche and Ex­elix­is post ear­ly PhI­II win for Tecen­triq/Cabome­tyx com­bo — but will wait for OS da­ta

Last year
R&D

FDA ap­proves high dose of Re­gen­eron's eye treat­ment Eylea in quick bounce­back from June re­jec­tion

Last year
FDA+

Ab­b­Vie ex­plores the emo­tion­al side of rare chron­ic can­cer in on­go­ing CLL video se­ries

Last year
Marketing

FDA ap­proves Re­gen­eron's an­ti­body for rare im­mune dis­ease, re­solves man­u­fac­tur­ing is­sues for afliber­cept

Last year
FDA+

AARP, in am­i­cus brief, ar­gues that CMS ne­go­ti­at­ing drug prices is in the pub­lic in­ter­est

Last year
FDA+

Mul­ti-task­ing doc­tors at home are watch­ing TV and re­search­ing phar­ma ads — on Google and even EMRs, sur­vey finds

Last year
Marketing

Gilead tracks five years of HIV grant giv­ing in hard-hit US South, and dou­bles down on new ap­proach­es

Last year
Marketing

Blue Shield of Cal­i­for­nia breaks off from phar­ma­cy ben­e­fit man­ag­er in new deal with Ama­zon and Mark Cuban

Last year

Doc­tors With­out Bor­ders re­jects Vi­iV Health­care's pro­posed con­tract for long-act­ing HIV PrEP drug

Last year

DOJ plans to take mifepri­s­tone chal­lenge to the Supreme Court

Last year
FDA+
Law

FDA ap­proves Ipsen's ul­tra-rare dis­ease drug palo­varotene

Last year
FDA+

Ab­b­Vie rais­es aware­ness around men­tal health and skin con­di­tions with pa­tients, docs and a celebri­ty spokesper­son

Last year
Marketing

Mallinck­rodt con­sid­ers Chap­ter 11 as ‘ad­vanced dis­cus­sions’ con­tin­ue

Last year

Flori­da adds ne­glect­ed FOIA re­quests to amend­ed law­suit against FDA over drug im­ports

Last year
FDA+

Te­va tri­al over al­leged Medicare kick­backs stopped while pend­ing ap­peal of po­ten­tial $10B judg­ment

Last year
Law

An­oth­er Eylea com­peti­tor pre­pares to en­ter the ring fol­low­ing pos­i­tive PhI­II read­out

Last year
FDA+

Leg­end im­proves ac­cess to Carvyk­ti, but cell ther­a­py lags de­mand as biotech seeks ear­li­er-line ap­proval

Last year
Cell/Gene Tx

Tetra Pharm opens new head­quar­ters to boost cannabi­noid drug re­search and man­u­fac­tur­ing

Last year
Manufacturing

Sanofi bid first, but Bio­gen won out in fight to ac­quire Rea­ta — re­port 

Last year
First page Previous page 107108109110111112113 Next page Last page
A service from the Financial Times